Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

PFIZER INC
Mes dernières consult.
Most popular
  Report  
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Latest news on PFIZER INC
05/26WATCH : First Viagra ad aired on UK TV
AQ
05/26PFIZER : will have to cut price of AML drug Mylotarg after NICE ruling
AQ
05/26GLOBAL ACTIVE PHARMACEUTICAL INGREDI : Pfizer, Inc., Novartis International AG, ..
AQ
05/25PFIZER : Biosimilar RETACRIT® epoetin alfa-epbx Approved by U.S. FDA
AQ
05/25PFIZER : Roivant Expands Senior Leadership with Key Hires
AQ
05/25PFIZER : Investigators at Pfizer Report Findings in Breast Cancer (Real-world ev..
AQ
05/25STUDY FINDINGS FROM PFIZER PROVIDE N : Adapting and Evaluating...
AQ
05/25PFIZER : Data from Pfizer Provide New Insights into Asthma (Proteomic analysis o..
AQ
05/25PFIZER : Oncology to Showcase Clinical Advances from its Growing Portfolio and R..
AQ
05/25INVACARE CORPORATION : Appoints Petra Danielsohn-Weil, PhD, to Board of Director..
AQ
05/25PFIZER : LYRICA® pregabalin Oral Solution CV Phase 3 Trial in Pediatric Epilepsy..
AQ
05/25The Heated Quest for Opioid Alternatives -2-
DJ
05/25The Heated Quest for Opioid Alternatives
DJ
05/25PFIZER : GEA and Perceptive Engineering – a partnership for the global pha..
AQ
05/25PFIZER : Merck, Pfizer power tumor profiling firm Strata to $26M round
AQ
05/25PFIZER : Anti-infectives play Iterum raises $80M in IPO
AQ
05/25PFIZER : ACCC unsuccessful in appeal against Pfizer
AQ
05/25PFIZER : Plans to Pay $24 Million To Settle Probe Over Medicare -- WSJ
DJ
05/25PFIZER : To pay $23.85m in settlement
AQ
05/25PFIZER : Australian anti-trust watchdog loses appeal against Pfizer over Lipitor..
RE
05/25Pfizer to pay $23.85 million to settle U.S. co-payment kickback probe
RE
05/24INVACARE : Adds to Its Board of Directors
AQ
05/24PFIZER : to pay $23.85 million to resolve dispute over kickbacks
AQ
05/24PFIZER : Drug Maker Pfizer Agrees to Pay $23.85 Million to Resolve False Claims ..
AQ
05/24PFIZER : Agrees to Pay $23.85 Million to Resolve Allegations that it Paid Kickba..
AQ
05/24PFIZER : to Pay $24 Million to Settle Probe Into Copay Assistance Charities--Upd..
DJ
05/24PFIZER : to Pay $24 Million to Settle Probe Into Copay Assistance Charities
DJ
05/24PFIZER INC. : - A Study Analyzing Observational Data Shows Real-World Effectiven..
AQ
05/24ALLERGY MEDICINE MARKET SCENARIO FOC : The global Allergy Medicine market Resear..
AQ
05/24PFIZER : Reaches $23.85 Million Settlement Agreement To Resolve Allegations Rela..
PU
05/24Keytruda improves survival in first-line squamous NSCLC
AQ
05/24PFIZER : Viagra makes one man dance again for Pfizer in first terrestrial TV ad ..
AQ
05/24PFIZER : RSV Vaccine Candidate Intends to Increase Neutralizing Antibody Levels ..
AQ
05/24PFIZER : recalls 1.8 million vials of antibiotics
AQ
05/24PFIZER : begins testing RSV vaccine in healthy adults
AQ
05/23SPARK THERAPEUTICS : Pfizer eye phase 3 trial of haemophilia B gene therapy
AQ
05/23SPARK THERAPEUTICS : and Pfizer Announce Data from 15 Participants with Hemophil..
AQ
05/23PFIZER : starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunt..
AQ
05/23SPARK THERAPEUTICS : hemophilia B gene therapy clears test en route to Pfizer-sp..
AQ
05/23PFIZER : Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) ..
AQ
05/23PFIZER : FDA Grants Breakthrough Therapy Designation for Tafamidis for the Treat..
BU
05/23PFIZER : A Study Analyzing Observational Data Shows Real-World Effectiveness of ..
AQ
05/23Astellas unveils new R&D strategy
AQ
05/22PFIZER : A Study Analyzing Observational Data Shows Real-World Effectiveness of ..
BU
05/22ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/..
AQ
05/22PFIZER : Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) ..
BU
05/22AMERISOURCEBERGEN : AG Wilson Joins Walgreens to Announce Expansion of Safe Medi..
AQ
05/22PFIZER : The New York Academy of Medicine to Honor Dr. Freda Lewis-Hall and Dr. ..
AQ
05/22Group identifies six core outcomes for hemophilia gene therapies
AQ
05/21PFIZER INC. : - LYRICA Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meet..
AQ
05/21EU Approves GlaxoSmithKline JV's Juluca HIV Treatment
DJ
05/21VIIV HEALTHCARE : Receives EU Marketing Authorisation for Juluca (dolutegravir/r..
BU
05/21KARO PHARMA : Receives milestone payment for rorgamma project from pfizer
AQ
05/19PFIZER : Sen. Durbin Calls for Transparency From Pharmaceutical Companies in Adv..
AQ
05/19PFIZER : to present clinical advances from its growing portfolio & research pipe..
AQ
05/19PFIZER : Pfizers Lyrica meets primary endpoint in phase 3 pediatric epilepsy tri..
AQ
05/18PFIZER : LYRICA (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epileps..
AQ
05/18AstraZeneca insists future is bright after big Crestor sales hit
RE
05/18PFIZER : FDA approves Pfizers Retacrit biosimilar to treat anaemia
AQ
05/18PFIZER : EpiPens remain available locally but are in short supply
AQ
05/18PFIZER : Around the World, People Living with Ulcerative Colitis Share Common Pe..
PU
05/18PFIZER : Senator Also Highlights Increase In Drug Prices And Critical Medicine S..
AQ
05/18PFIZER : Looking for an EpiPen?
AQ
05/17PFIZER : Enforce anti-counterfeit, illicit drug use laws
AQ
05/17PFIZER : New Bioanalysis Findings from Pfizer Described (HPLC-high-resolution ma..
AQ
05/17PFIZER : Recent Findings from Pfizer Has Provided New Information about Organic ..
AQ
05/17INVACARE CORPORATION : Appoints Petra Danielsohn-Weil, PhD, to Board of Director..
BU
05/17PFIZER : Researchers at Pfizer Release New Data on Cytokines (Discovery of a Nov..
AQ
05/17PFIZER : Findings from Pfizer Yields New Findings on Amyloid [Identification of ..
AQ
05/17PFIZER : Researchers at Pfizer Target Nephrology (LC-MS/MS assay for N1-methylni..
AQ
05/17PFIZER : Investigators from Pfizer Target Organic Research (Ir-Catalyzed Borylat..
AQ
05/17PFIZER : Reports from Pfizer Highlight Recent Findings in Rheumatoid Arthritis (..
AQ
05/17PFIZER : Reports Summarize Fibromyalgia Findings from Pfizer (Effect of Baseline..
AQ
05/17Takeda CEO prescribes surgical R&D cuts after $62 billion Shire deal
RE
05/17Takeda CEO prescribes surgical R&D cuts after $62 billion Shire deal
RE
1  2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2018 54 391 M
EBIT 2018 20 753 M
Net income 2018 12 828 M
Debt 2018 21 840 M
Yield 2018 3,83%
P/E ratio 2018 15,89
P/E ratio 2019 15,13
EV / Sales 2018 4,24x
EV / Sales 2019 4,05x
Capitalization 209 B
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 39,6 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Albert Bourla Chief Operating Officer & Director
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
W. Don Cornwell Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC208 713
JOHNSON & JOHNSON-11.45%325 801
PFIZER-0.91%208 713
NOVARTIS-8.30%194 397
ROCHE HOLDING LTD.-9.17%189 708
MERCK AND COMPANY5.01%158 970